Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission

Allogeneic hematopoietic stem cell transplantation (allo-SCT) is potentially curative for patients with high-risk leukemia, but disease recurrence remains the leading cause of treatment failure. Our objective was to determine the impact of minimal residual disease (MRD) by any technique in adult pat...

Full description

Bibliographic Details
Main Authors: Rada M. Grubovikj, Asif Alavi, Ahrin Koppel, Mary Territo, Gary J. Schiller
Format: Article
Language:English
Published: MDPI AG 2012-06-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/4/2/601